New biomarkers from multiomics approaches: improving risk prediction of atrial fibrillation
Open Access
- 5 March 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 117 (7) , 1632-1644
Abstract
Atrial fibrillation (AF) is a common cardiac arrhythmia leading to many adverse outcomes and increased mortality. Yet the molecular mechanisms underlying AF remain largely unknown. Recent advances in high-throughput technologies make large-scale molecular profiling possible. In the past decade, multiomics studies of AF have identified a number of potential biomarkers of AF. In this review, we focus on the studies of multiomics profiles with AF risk. We summarize recent advances in the discovery of novel biomarkers for AF through multiomics studies. We also discuss limitations and future directions in risk assessment and discovery of therapeutic targets for AF.Keywords
Funding Information
- HORIZON EUROPE Marie Sklodowska-Curie Actions
- European Union’s Horizon 2020 Research and Innovation Programme (838259)
- American Heart Association (18SFRN34150007)
- American College of Cardiology Foundation
- Merck Research Fellowship in Cardiovascular Diseases and Cardiometabolic Disorders
- National Institutes of Health (5R01HL128914)
- National Institutes of Health (2R01 HL092577)
- National Institutes of Health (1R01 HL141434 01A1)
- National Institutes of Health (2U54HL120163)
- National Institutes of Health (1R01AG066010)
- American Heart Association (18SFRN34110082)
- European Commission Grant (847770)
This publication has 148 references indexed in Scilit:
- Meta-analysis identifies six new susceptibility loci for atrial fibrillationNature Genetics, 2012
- Lack of replication in polymorphisms reported to be associated with atrial fibrillationHeart Rhythm, 2011
- Association Between Familial Atrial Fibrillation and Risk of New-Onset Atrial FibrillationJAMA, 2010
- Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort studyThe Lancet, 2009
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- Application of Metabolomics to Cardiovascular Biomarker and Pathway DiscoveryJACC, 2008
- A first-degree family history in lone atrial fibrillation patientsHeart Rhythm, 2008
- Genetics of gene expression and its effect on diseaseNature, 2008
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Hypoxia-Inducible Factor 1-Alpha Reduces Infarction and Attenuates Progression of Cardiac Dysfunction After Myocardial Infarction in the MouseJACC, 2005